Access to genomic testing, not therapy cost, is the biggest challenge
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
